0000899243-22-009517.txt : 20220304
0000899243-22-009517.hdr.sgml : 20220304
20220304194616
ACCESSION NUMBER: 0000899243-22-009517
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210803
FILED AS OF DATE: 20220304
DATE AS OF CHANGE: 20220304
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Rahilly Sean
CENTRAL INDEX KEY: 0001621195
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35503
FILM NUMBER: 22715864
MAIL ADDRESS:
STREET 1: C/O ENOVA INTERNATIONAL, INC.
STREET 2: 175 W. JACKSON BLVD.
CITY: CHICAGO
STATE: IL
ZIP: 60604
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Enova International, Inc.
CENTRAL INDEX KEY: 0001529864
STANDARD INDUSTRIAL CLASSIFICATION: PERSONAL CREDIT INSTITUTIONS [6141]
IRS NUMBER: 453190813
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 175 WEST JACKSON BLVD.
STREET 2: SUITE 1000
CITY: CHICAGO
STATE: IL
ZIP: 60604
BUSINESS PHONE: 312-568-4200
MAIL ADDRESS:
STREET 1: 175 WEST JACKSON BLVD.
STREET 2: SUITE 1000
CITY: CHICAGO
STATE: IL
ZIP: 60604
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-08-03
0
0001529864
Enova International, Inc.
ENVA
0001621195
Rahilly Sean
C/O ENOVA INTERNATIONAL, INC.
175 W. JACKSON BOULEVARD, SUITE 1000
CHICAGO
IL
60604
0
1
0
0
General Counsel and Secretary
Common stock, par value $0.00001 per share
2021-10-15
4
S
0
1430
36.5907
D
80127
D
Stock Option (right to buy) with limited SAR
31.98
2021-08-03
4
A
0
4504
0.00
A
2028-08-03
Common stock, par value $0.00001 per share
4504
112401
D
Stock Option (right to buy) with limited SAR
35.75
2021-11-04
4
A
0
4580
0.00
A
2028-11-04
Common stock, par value $0.00001 per share
4580
116981
D
The sales were made pursuant to a Rule 10b5-1 trading plan dated 3/18/2021 adopted by the reporting person.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.34 to $36.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range. The sales were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person.
The limited stock appreciation right ("SAR") and employee stock option were granted in tandem. Accordingly, the exercise of one results in the expiration of the other. The SAR may be exercised only during the period beginning on the first day following the date that a "Change in Control" of Issuer occurs (as defined in the related grant agreement) and ending on the thirtieth day following such date. Upon exercise, the grantee shall be able to receive an amount equal to the product computed by multiplying (i) the excess of the "Offer Value Per Share" over the exercise price of the underlying option by (ii) the number of shares with respect to which the SAR is being exercised; provided, that such amount shall only be payable in the event an "Offer" is made.
The "Offer Value Per Share" means the average selling price of Issuer's common stock during the period of 30 days ending on the date on which the SAR is exercised. "Offer" means any tender offer or exchange offer for outstanding shares of Issuer representing at least 30% of the total voting power of the stock of Issuer, or an offer to purchase assets from Issuer that have a total gross fair market value equal to or more than 40% of the total gross fair market value of all of the assets of Issuer, other than an offer made by Issuer.
The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 3, 2023, February 3, 2024 and February 3, 2025.
The options shall vest in substantially equal one-third increments on each of the following dates as long as grantee serves as an employee of Issuer or an affiliate thereof through the applicable vesting date: February 4, 2023, February 4, 2024 and February 4, 2025.
/s/ Sean Rahilly
2022-03-04